Testosterone propionate
Alternative Names: Synandrol; Synerone; Testosterone Propionate Injection; TestovironLatest Information Update: 24 Oct 2021
At a glance
- Originator Unknown
- Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Breast cancer; Decreased libido; Delayed puberty; Hypogonadism; Menopausal syndrome
Most Recent Events
- 22 Sep 2010 Taro Pharmaceutical Industries has been acquired by Sun Pharmaceutical Industries
- 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
- 17 Jan 2000 Launched for Breast cancer in Italy (IM)